Description: ViewRay, Inc. designs, manufactures, and markets radiation therapy systems worldwide. It offers MRIdian, a magnetic resonance imaging-guided radiation therapy system that images and treats cancer patients simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. The company markets its MRIdian through a direct sales force in the United States and distributors worldwide to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. was founded in 2004 and is headquartered in Oakwood Village, Ohio.
Home Page: www.viewray.com
VRAY Technical Analysis
2 Thermo Fisher Way
Oakwood,
OH
44146
United States
Phone:
440 703 3210
Officers
| Name | Title |
|---|---|
| Mr. Scott William Drake | Pres, CEO & Director |
| Mr. Zachary William Stassen | Chief Financial Officer |
| Mr. Robert S. McCormack | Chief Legal Officer |
| Mr. Paul Ziegler Jr., J.D. | Chief Commercial Officer |
| Dr. James F. Dempsey Ph.D. | Founder & Chief Scientific Officer |
| Drew Hill | Sr. VP of Operations & Devel. |
| Matt Harrison | Director of Investor Relations |
| Karen Hackstaff | VP of Marketing |
| Mr. Robert Michael Fuchs | Chief HR Officer |
| Dr. Martin Fuss M.D., Ph.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.9871 |
| Price-to-Sales TTM: | 9.4214 |
| IPO Date: | 2015-12-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 267 |